Form 4 for VRDN Viridian Therapeutics, Inc.\DE
Accepted 2026-01-02 00:00:00 ET · period of report 2025-12-31 · accession 0001193125-26-001097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-02 | 2025-12-31 | VRDN | Tousignant Jennifer | CLO | S - Sale | $31.16 | -2,272 | 0 | -100% | -$70.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | S | D | 2,272 | $31.16 | 0 | D | — | — | (F1) Consists of shares purchased under the Issuer's employee stock purchase plan. |